Overview

• The Court is reviewing a challenge to FDA-approved mifepristone, a key medication for abortions.
• A separate case involves whether emergency abortion care is mandated under federal law.
• Legal standing of anti-abortion plaintiffs is a critical issue in both cases.
• Decisions are expected by late June or early July, potentially impacting upcoming elections.
• States like Missouri, Kansas, and Idaho may continue legal battles regardless of the rulings.